• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下调心脏 PIASy 可抑制 Cx43 SUMOylation,改善心肌缺血/再灌注损伤大鼠模型中的室性心律失常。

Downregulation of cardiac PIASy inhibits Cx43 SUMOylation and ameliorates ventricular arrhythmias in a rat model of myocardial ischemia/reperfusion injury.

机构信息

Department of Anesthesiology, Institute of Anesthesiology and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.

Department of Anesthesiology, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, China.

出版信息

Chin Med J (Engl). 2023 Jun 5;136(11):1349-1357. doi: 10.1097/CM9.0000000000002618.

DOI:10.1097/CM9.0000000000002618
PMID:37014755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10309519/
Abstract

BACKGROUND

Dysfunction of the gap junction channel protein connexin 43 (Cx43) contributes to myocardial ischemia/reperfusion (I/R)-induced ventricular arrhythmias. Cx43 can be regulated by small ubiquitin-like modifier (SUMO) modification. Protein inhibitor of activated STAT Y (PIASy) is an E3 SUMO ligase for its target proteins. However, whether Cx43 is a target protein of PIASy and whether Cx43 SUMOylation plays a role in I/R-induced arrhythmias are largely unknown.

METHODS

Male Sprague-Dawley rats were infected with PIASy short hairpin ribonucleic acid (shRNA) using recombinant adeno-associated virus subtype 9 (rAAV9). Two weeks later, the rats were subjected to 45 min of left coronary artery occlusion followed by 2 h reperfusion. Electrocardiogram was recorded to assess arrhythmias. Rat ventricular tissues were collected for molecular biological measurements.

RESULTS

Following 45 min of ischemia, QRS duration and QTc intervals statistically significantly increased, but these values decreased after transfecting PIASy shRNA. PIASy downregulation ameliorated ventricular arrhythmias induced by myocardial I/R, as evidenced by the decreased incidence of ventricular tachycardia and ventricular fibrillation, and reduced arrythmia score. In addition, myocardial I/R statistically significantly induced PIASy expression and Cx43 SUMOylation, accompanied by reduced Cx43 phosphorylation and plakophilin 2 (PKP2) expression. Moreover, PIASy downregulation remarkably reduced Cx43 SUMOylation, accompanied by increased Cx43 phosphorylation and PKP2 expression after I/R.

CONCLUSION

PIASy downregulation inhibited Cx43 SUMOylation and increased PKP2 expression, thereby improving ventricular arrhythmias in ischemic/reperfused rats heart.

摘要

背景

缝隙连接通道蛋白连接蛋白 43(Cx43)的功能障碍导致心肌缺血/再灌注(I/R)诱导的室性心律失常。Cx43 可通过小泛素样修饰物(SUMO)修饰进行调节。蛋白抑制物激活 STAT Y(PIASy)是其靶蛋白的 E3 SUMO 连接酶。然而,Cx43 是否是 PIASy 的靶蛋白,以及 Cx43 SUMO 化在 I/R 诱导的心律失常中是否起作用,在很大程度上尚不清楚。

方法

雄性 Sprague-Dawley 大鼠用重组腺相关病毒 9(rAAV9)感染 PIASy 短发夹 RNA(shRNA)。两周后,大鼠进行 45 分钟左冠状动脉阻塞,然后再灌注 2 小时。记录心电图以评估心律失常。收集大鼠心室组织进行分子生物学测量。

结果

缺血 45 分钟后,QRS 持续时间和 QTc 间期显著增加,但转染 PIASy shRNA 后这些值降低。PIASy 下调改善了心肌 I/R 诱导的室性心律失常,表现为室性心动过速和室颤的发生率降低,心律失常评分降低。此外,心肌 I/R 显著诱导 PIASy 表达和 Cx43 SUMO 化,伴随着 Cx43 磷酸化和 plakophilin 2(PKP2)表达降低。此外,PIASy 下调后,I/R 后 Cx43 SUMO 化明显减少,Cx43 磷酸化和 PKP2 表达增加。

结论

PIASy 下调抑制 Cx43 SUMO 化并增加 PKP2 表达,从而改善缺血/再灌注大鼠心脏的室性心律失常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/4cf089657141/cm9-136-1349-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/3d537d0af7d8/cm9-136-1349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/f6988148719e/cm9-136-1349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/a16b2cf6f915/cm9-136-1349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/3e29cf557766/cm9-136-1349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/76db02108ff4/cm9-136-1349-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/4cf089657141/cm9-136-1349-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/3d537d0af7d8/cm9-136-1349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/f6988148719e/cm9-136-1349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/a16b2cf6f915/cm9-136-1349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/3e29cf557766/cm9-136-1349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/76db02108ff4/cm9-136-1349-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a519/10309519/4cf089657141/cm9-136-1349-g006.jpg

相似文献

1
Downregulation of cardiac PIASy inhibits Cx43 SUMOylation and ameliorates ventricular arrhythmias in a rat model of myocardial ischemia/reperfusion injury.下调心脏 PIASy 可抑制 Cx43 SUMOylation,改善心肌缺血/再灌注损伤大鼠模型中的室性心律失常。
Chin Med J (Engl). 2023 Jun 5;136(11):1349-1357. doi: 10.1097/CM9.0000000000002618.
2
Cardiac-targeted PIASy gene silencing mediates deSUMOylation of caveolin-3 and prevents ischemia/reperfusion-induced Na1.5 downregulation and ventricular arrhythmias.心脏靶向的 PIASy 基因沉默介导 caveolin-3 的去 SUMOylation,防止缺血/再灌注诱导的 Na1.5 下调和室性心律失常。
Mil Med Res. 2022 Oct 14;9(1):58. doi: 10.1186/s40779-022-00415-x.
3
Effects of Pinocembrin Pretreatment on Connexin 43 (Cx43) Protein Expression After Rat Myocardial Ischemia-Reperfusion and Cardiac Arrhythmia.姜黄酮预处理对大鼠心肌缺血再灌注及心律失常后连接蛋白 43(Cx43)蛋白表达的影响。
Med Sci Monit. 2018 Jul 19;24:5008-5014. doi: 10.12659/MSM.909162.
4
Connexin 43 dephosphorylation contributes to arrhythmias and cardiomyocyte apoptosis in ischemia/reperfusion hearts.间隙连接蛋白 43 去磷酸化导致缺血/再灌注心脏心律失常和心肌细胞凋亡。
Basic Res Cardiol. 2019 Aug 28;114(5):40. doi: 10.1007/s00395-019-0748-8.
5
The Protective Effects of Preconditioning With Dioscin on Myocardial Ischemia/Reperfusion-Induced Ventricular Arrhythmias by Increasing Connexin 43 Expression in Rats.薯蓣皂苷元预处理通过增加大鼠连接蛋白 43 的表达对心肌缺血/再灌注诱导的室性心律失常的保护作用。
J Cardiovasc Pharmacol Ther. 2019 May;24(3):262-268. doi: 10.1177/1074248418801567. Epub 2018 Nov 26.
6
Antiarrhythmic effect of sevoflurane as an additive to HTK solution on reperfusion arrhythmias induced by hypothermia and ischaemia is associated with the phosphorylation of connexin 43 at serine 368.七氟醚作为 HTK 溶液添加剂对低温和缺血再灌注心律失常的抗心律失常作用与连接蛋白 43 丝氨酸 368 磷酸化有关。
BMC Anesthesiol. 2019 Jan 8;19(1):5. doi: 10.1186/s12871-018-0656-8.
7
Anti-arrhythmic effect of verapamil is accompanied by preservation of cx43 protein in rat heart.维拉帕米的抗心律失常作用伴随着 cx43 蛋白在大鼠心脏中的保留。
PLoS One. 2013 Aug 12;8(8):e71567. doi: 10.1371/journal.pone.0071567. eCollection 2013.
8
Selenium status as determinant of connexin-43 dephosphorylation in ex vivo ischemic/reperfused rat myocardium.硒状态作为离体缺血/再灌注大鼠心肌中连接蛋白43去磷酸化的决定因素
J Trace Elem Med Biol. 2005;19(1):43-7. doi: 10.1016/j.jtemb.2005.07.001.
9
Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.在E3连接酶PIASy中鉴定一种新的小泛素样修饰物(SUMO)相互作用基序。
J Biol Chem. 2017 Jun 16;292(24):10230-10238. doi: 10.1074/jbc.M117.789982. Epub 2017 Apr 28.
10
Loss of anti-arrhythmic effect of vagal nerve stimulation on ischemia-induced ventricular tachyarrhythmia in aged rats.老龄大鼠缺血性室性心律失常时迷走神经刺激抗心律失常作用的丧失。
Tohoku J Exp Med. 2011 Jan;223(1):27-33. doi: 10.1620/tjem.223.27.

引用本文的文献

1
Research progress of connexin 43 in cardiovascular diseases.连接蛋白43在心血管疾病中的研究进展
Front Cardiovasc Med. 2025 Aug 22;12:1650548. doi: 10.3389/fcvm.2025.1650548. eCollection 2025.
2
The multifaceted nature of SUMOylation in heart disease and its therapeutic potential.SUMO化修饰在心脏病中的多面性及其治疗潜力。
Mol Cell Biochem. 2025 Apr 27. doi: 10.1007/s11010-025-05286-z.
3
Study on the mechanisms and Pharmacodynamic substances of Lian-Gui-Ning-Xin-Tang on Arrhythmia Therapy based on Pharmacodynamic-Pharmacokinetic associations.
基于药效-药代动力学关联的连归宁心汤治疗心律失常的作用机制及药效物质研究
Heliyon. 2024 Aug 14;10(16):e36104. doi: 10.1016/j.heliyon.2024.e36104. eCollection 2024 Aug 30.
4
Post translational modifications of connexin 43 in ventricular arrhythmias after myocardial infarction.翻译:心肌梗死后心室心律失常中连接蛋白 43 的翻译后修饰。
Mol Biol Rep. 2024 Feb 23;51(1):329. doi: 10.1007/s11033-024-09290-2.
5
Research progress on post-translational modification of proteins and cardiovascular diseases.蛋白质翻译后修饰与心血管疾病的研究进展
Cell Death Discov. 2023 Jul 28;9(1):275. doi: 10.1038/s41420-023-01560-5.